2014 | Erdheim-Chester Disease Global Alliance

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease.

by Asmaa Javed | Dec 28, 2014 | Published Papers

Janku F, Vibat CR, Kosco K, Holley VR, Cabrilo G, Meric-Bernstam F, Stepanek VM, Lin PP, Leppin L, Hassaine L, Poole JC, Kurzrock R, Erlander MG. Oncotarget. 2014 Jun 15;5(11):3607-10.

Erdheim-Chester – a rare disease with unique endoscopic features.

by Asmaa Javed | Dec 28, 2014 | Published Papers

Ben-Yaakov G, Munteanu D, Sztarkier I, Fich A, Schwartz D. World J Gastroenterol. 2014 Jul 7;20(25):8309-11. doi: 10.3748/wjg.v20.i25.8309.

Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings.

by Asmaa Javed | Dec 28, 2014 | Published Papers

Antunes C, Graça B, Donato P. Insights Imaging. 2014 Aug;5(4):473-82. doi: 10.1007/s13244-014-0331-7. Epub 2014 Jul 14.

High-dose methotrexate for the treatment of relapsed central nervous system erdheim-chester disease.

by Asmaa Javed | Dec 28, 2014 | Published Papers

Ho P, Smith C. Case Rep Hematol. 2014;2014:269359. doi: 10.1155/2014/269359. Epub 2014 Jun 16.

Histiocytosis: a review focusing on neuroimaging findings.

by Asmaa Javed | Dec 28, 2014 | Published Papers

Gabbay LB, Leite Cda C, Andriola RS, Pinho Pda C, Lucato LT. Arq Neuropsiquiatr. 2014 Jul;72(7):548-58.

BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease.

Erdheim-Chester – a rare disease with unique endoscopic features.

Thoracic, abdominal and musculoskeletal involvement in Erdheim-Chester disease: CT, MR and PET imaging findings.

High-dose methotrexate for the treatment of relapsed central nervous system erdheim-chester disease.

Histiocytosis: a review focusing on neuroimaging findings.

Search Our Blogs

Recent Posts

Back to Top

Join Us

Donate

Care Centers

Events